Orion Oyj (OTCMKTS:ORINF) Shares Up 3.2% – Here’s What Happened
by Doug Wharley · The Cerbat GemOrion Oyj (OTCMKTS:ORINF – Get Free Report) shares were up 3.2% during trading on Wednesday . The company traded as high as $48.65 and last traded at $48.65. Approximately 200 shares changed hands during mid-day trading, a decline of 81% from the average daily volume of 1,080 shares. The stock had previously closed at $47.16.
Orion Oyj Trading Up 3.2 %
The stock has a 50-day moving average price of $47.16 and a 200 day moving average price of $47.16.
Orion Oyj Company Profile
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.
Recommended Stories
- Five stocks we like better than Orion Oyj
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- What Investors Need to Know About Upcoming IPOs
- 3 Penny Stocks Ready to Break Out in 2025
- Market Cap Calculator: How to Calculate Market Cap
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential